Etravirine-based antiretroviral therapy in HIV/hepatitis C virus coinfected advanced fibrosis patients receiving triple therapy against hepatitis C virus with telaprevir

dc.contributor.authorRamírez, María Luisa
dc.contributor.authorVargas, Francisco X.
dc.contributor.authorGonzález García, Juan
dc.contributor.authorQuereda, Carmen
dc.contributor.authorPérez Elías, María Jesús
dc.contributor.authorCea, Álvaro de
dc.contributor.authorBarros, Carlos
dc.contributor.authorCondés Moreno, Emilia
dc.contributor.authorMoreno, José
dc.contributor.authorMoreno, Ana
dc.contributor.authorEt al.
dc.date.accessioned2019-07-10T15:50:05Z
dc.date.available2019-07-10T15:50:05Z
dc.date.issued2014
dc.description.filiationUEMspa
dc.description.impact5.554 JCR (2014) Q1, 5/33 Virology, 21/148 Immunology, 7/78 Infectious Diseasesspa
dc.description.sponsorshipSin financiaciónspa
dc.identifier.citationRamirez, M. L. M., Vargas, F. X. Z., Gonzalez-Garcia, J., Quereda, C., Perez-Elias, M. J., de Cea, A. M., … Moreno, A. (2014). Etravirine-based antiretroviral therapy in HIV/hepatitis C virus coinfected advanced fibrosis patients receiving triple therapy against hepatitis C virus with telaprevir. AIDS (London, England), 28(16), 2487–2489. https://doi.org/10.1097/QAD.0000000000000425spa
dc.identifier.doi10.1097/QAD.0000000000000425
dc.identifier.issn02699370
dc.identifier.urihttp://hdl.handle.net/11268/8114
dc.language.isoengspa
dc.peerreviewedSispa
dc.rights.accessRightsrestricted accessspa
dc.subject.uemHepatitisspa
dc.subject.uemFibrosisspa
dc.subject.uemSIDAspa
dc.subject.unescoSidaspa
dc.subject.unescoTratamiento médicospa
dc.titleEtravirine-based antiretroviral therapy in HIV/hepatitis C virus coinfected advanced fibrosis patients receiving triple therapy against hepatitis C virus with telaprevirspa
dc.typejournal articlespa
dspace.entity.typePublication
relation.isAuthorOfPublicationadd36d97-9c9a-41d8-91f2-5aee4000b5f9
relation.isAuthorOfPublication.latestForDiscoveryadd36d97-9c9a-41d8-91f2-5aee4000b5f9

Files